Cite
HARVARD Citation
Pfeil, A. et al. (n.d.). THU0121 Low Disease Activity and ACR70-Response Is Associated with The Inhibition of Periarticular Bone Loss in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol plus Methotrexate. Annals of the rheumatic diseases. p. 223. [Online].